Reduced transplant arteriosclerosis in murine cardiac allografts placed in interferon-γ knockout recipients

American Journal of Pathology

Volumn 152, Issue 2, 1998, Pages 359-365

  Räisänen Sokolowski, Anne ^a   Glysing Jensen, Troels ^a   Koglin, Jörg ^a   Russell, Mary E ^a,b,c  

^a HARVARD MEDICAL SCHOOL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ACTIN; ELASTIN; GAMMA INTERFERON;

ALLOGRAFT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOSCLEROSIS; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; GENE DELETION; HEART TRANSPLANTATION; IMMUNOHISTOCHEMISTRY; INTIMA; MICROSCOPY; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ARTERIOSCLEROSIS; HEART TRANSPLANTATION; INTERFERON TYPE II; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIUM; POSTOPERATIVE COMPLICATIONS; TRANSPLANTATION, HOMOLOGOUS; TUNICA INTIMA;

EID: 0348201197     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Abbas A, Lichtman A, Pober J: Cellullar and Molecular Immunology, ed 2. Philadelphia, W.B. Saunders Company, 1994
2. Hansson GK, Jonasson L, Holm J, Clowes MM, Clowes AW: Gamma-interferon regulates vascular smooth muscle proliferation and Ia antigen expression in vivo and in vitro. Circ Res 1988, 63:712-719
3. Hansson G, Holm J: Interferon-γ inhibits arterial stenosis after injury. Circulation 1991, 84:1266-1272
4. Castronuovo JJ Jr, Guss S, Mysh D, Sawhney A, Wolff M, Gown A: Cytokine therapy for arterial restenosis: inhibition of neointimal hyperplasia by γ-interferon. Cardiovasc Surg 1995, 3:463-468
5. Dalton DK, Pitts-Meek S, Keshav S, Figari IS, Bradley A, Stewart TA: Multiple defects of immune cell function in mce with disrupted interferon-γ genes. Science 1993, 259:1739-1742
6. Huang S, Hendriks W, AIthago A, Hemmi S, Bluethmann H, Kamijo R, Vilcek J, Zinkernagel R, Aguet M: Immune response in mice that lack the interferon-γ receptor. Science 1993, 259:1742-1745
7. Goes N, Urmson J, Hobart M, Halloran P: The unique role of interfer. on-γ in the regulation of MHC expression on arterial endothelium. Transplantation l996, 62:1889-1894
8. Menourny-Schwartz B, Chiocchia G, Bessis N, Abehsira-Amar O, Betteux F, Muller S, Huang S, Boissier M, Fournier C: High susceptibility to collagen-induced arthritis in mice lacking IFN-γ receptors. J Immunol 1997, 158:5501-5506
9. Vermeire K, Heremans H, Vandeputte M, Huang S, Billiau A, Matthys P: Accelerated collagen-induced arthritis in IFN-γ recepto-deficient mice. J Immunol 1997, 158:5507-5513
10. Saleem S, Konieczny B, Lowry R, Baddoura F, Lakkis F: Acute rejection of vescularized heart allografts in the absence of IFN-γ. Trensplantation 1996, 62:1908-1911
11. Russell ME, Wallace AF, Hancock WW, Sayegh MH, Adams DH, Sibinga NES, Wyner LR, Karnovsky MJ: Upregulation of cytokines associated with macrophage activation n the Lewis to F344 rat chronic cardiac rejection model. Transplantation 1995, 59:572-578
12. Russell ME, Hancock WW, Akalin E, Wallace AF, Glysing-Jensen T, Willett T, Saygeh MH: Chronic cardiac rejection in the Lewis to F344 rat model: blockade of CD28-B7 costimulation by CTLA4Ig modulates T cell and macrophage activation and attenuates arteriosclerosis. J Clin Invest 1996, 97:833-838
13. Räisänen-Sokolowski A, Glysing-Jensen T, Mottram P, Russell M: Sustained anti-CD4/CD8 blocks inflammatory activation and intimal thickening in mouse heart allografts. Arterioscler Thromb Vasc Biol 1997, 17:2115-2122
14. Corry RJ, Winn HJ, Russell PS: Primarily vascularized allografts of hearts in mice: the role of H-2D, H-2K, and non-H-2 antigens in rejection. Transplantation 1973, 16:343-350
15. Shi C, Russell ME, Bianchi C, Newell JB, Haber E: Murine model of accelerated transplant arteriosclerosis. Circ Res 1994, 75:199-207
16. Adams D, Wyner L, Kamovsky M: Experimental graft arteriosclerosis: II. Immunocytochemical analysis of lesion development. Transplantation 1993, 56:794-799
17. Skalli O, Ropraz P, Trzeciak A, Benzonana G, Gillessen D, Gabbiani G: A monoclonal antibody against α-smooth muscle actin: a new probe for smooth muscle differentiation. J Cell Biol 1986, 103:2787-2796
18. Adams DH, Tilney NL, Collins JJ, Karnovsky MJ: Experimental graft arteriosclerosis: I. The Lewis-to-F-344 allograft model. Transplantation 1992, 53:1115-1119
19. Russell PS, Chase CM, Winn HJ, Colvin RB: Coronary atherosclerosis in transplanted mouse hearts: I. Time course and immunogenetic and immunopathological considerations. Am J Pathol 1994, 144:260-274
20. Russell P, Chase C, Winn H, Colvin R: Coronary atherosclerosis in transplanted mouse hearts: III. Effects of recipient treatment with monoclonal antibody to interferon-g. Transplantation 1994, 57:1367-1371
21. Nagano H, Mitchell R, Taylor M, Hasagawa S, Tilney N, Libby P. Interferon-γ deficiency prevents coronary arteriosclerosis but not myocardial rejection in transplanted mouse hearts. J Clin Invest 1997, 103:550-557
22. Billingham M: Chronic rejection in human allografts. Transplant Vascular Sclerosis. Edited by C Orosz, D Sedmak, R Ferguson. Austin, R. G. Lendes Company, 1995, pp 35-44
23. Gupta S, Pablo A, Jiang X, Wang N, Tall A, Schindlar C: IFN-γ potentiates atherosclerosis in ApoE knock-out mice. J Clin Invest 1997, 99:2752-2761
24. Bennett MR, Even GI, Newby AC: Deregulated expression of the c-myc oncogene abolishes inhibition of proliferation of rat vascular smooth muscle cells by serum reduction, interferon-γ, heparin, and cyclic nuclaotide analogues and induces apoptosis. Circ Res 1994, 74:525-536
25. Schwartz SM, deBlois D, O'Brien ER: The intima: soil for atherosclerosis and restenosis. Circ Res 1995, 77:445-465
26. Ross R: The pathogenesis of atherosclerosis: a perspective for the 1990s. Nature 1993, 362:801-809
27. Tullius SG, Tilney NL: Both alloantigen-dependent and -independent factors influence chronic allograft rejection. Transplantation 1995, 59:313-318
28. Wang ZE, Reiner SL, Zheng S, Dalton DK, Locksley RM. CD4+ effector cells default to the Th2 pathway in interferon γ-deficient mice infected with Leishmania major. J Exp Med 1994, 179:1367-1371
29. Dal W, Bartens W, Köhler G, Hufnagel M, Kopf M, Brombacher F: Impaired macrophage listericidal and cytokine activities are responsible for the rapid death of Listeria monocytogenes-infected IFN-γ receptor deficient mice. J Immunol 1997, 158:5297-5304
30. Szalay G, Ladel C, Blum C, Kaufmann S: IL-4 neutralization or TNF-α treatment ameliorate disease by an intracellular pathogen in IFN-γ receptor deficient mice. J Immunol 1996, 157:4746-4750
31. Räisänen-Sokolowski A, Mottram P, Glysing-Jensen T, Satoskar A, Russell M: Heart transplants in interferon-γ, interleukin 4 and interleukin 10 knockout mice: recipient environment alters graft rejection. J Clin Invest 1997, 100:2449-2456